77 related articles for article (PubMed ID: 9613989)
41. Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma.
Shimoyama M; Seki S; Nagai M; Minato K; Kitamura T; Hoshino H; Miwa M; Tobinai K; Nagoshi H; Oosuga T
Princess Takamatsu Symp; 1984; 15():71-6. PubMed ID: 6152761
[TBL] [Abstract][Full Text] [Related]
42. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
43. Adult T-cell leukemia (ATL) with an unusual immunophenotype and a high cellular proliferation rate.
Lorand-Metze I; Pombo-de-Oliveira MS
Leuk Lymphoma; 1996 Aug; 22(5-6):523-6. PubMed ID: 8882968
[TBL] [Abstract][Full Text] [Related]
44. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
[TBL] [Abstract][Full Text] [Related]
45. Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Shimamoto Y; Kobayashi M; Miyamoto Y
Leuk Lymphoma; 1996 Jan; 20(3-4):207-15. PubMed ID: 8624458
[TBL] [Abstract][Full Text] [Related]
46. CD45RO+ T-cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells.
Frolova EA; Scott SC; Jones RA
Leuk Lymphoma; 1995 Jun; 18(1-2):103-11. PubMed ID: 8580811
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
Kannagi M; Matsushita S; Shida H; Harada S
Leukemia; 1994 Apr; 8 Suppl 1():S54-9. PubMed ID: 8152305
[TBL] [Abstract][Full Text] [Related]
48. Variant type of sialyl Lewis X antigen expressed on adult T cell leukemia cells is associated with skin involvement.
Furukawa Y; Tara M; Ohmori K; Kannagi R
Cancer Res; 1994 Dec; 54(24):6533-8. PubMed ID: 7987853
[TBL] [Abstract][Full Text] [Related]
49. Relation of autonomous and interleukin-2-responsive growth of leukemic cells to survival in adult T-cell leukemia.
Arima N; Hidaka S; Fujiwara H; Matsushita K; Ohtsubo H; Arimura K; Kukita T; Fukumori J; Tanaka H
Blood; 1996 Apr; 87(7):2900-4. PubMed ID: 8639910
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of quantitative viral markers in adult T-cell leukemia/lymphoma.
Manns A; Miley WJ; Waters D; Hanchard B; Wharfe G; Cranston B; Williams E; Blattner WA
Blood; 1999 Jul; 94(1):372-3. PubMed ID: 10428547
[No Abstract] [Full Text] [Related]
51. Adult T-cell leukaemia with various abnormalities in endocrine and metabolic systems.
Adachi M; Shiomura T; Shimada H; Kishimoto N; Iida K; Ikeno H; Nishimura H; Inoue T; Sako Y
Br J Haematol; 1994 Aug; 87(4):853-5. PubMed ID: 7986728
[TBL] [Abstract][Full Text] [Related]
52. Adult T-cell leukemia with predominant skin involvement.
Nagatani T; Miyazawa M; Matsuzaki T; Horiuchi Y; Iemoto G; Sugita Y; Baba N; Sugiyama A; Nakajima H; Kitamura H
Int J Dermatol; 1998 Apr; 37(4):275-7. PubMed ID: 9585900
[No Abstract] [Full Text] [Related]
53. Can expression of CD45RO, a T-cell surface molecule, be used to detect congenital infection?
Michie C; Harvey D
Lancet; 1994 May; 343(8908):1259-60. PubMed ID: 7910277
[TBL] [Abstract][Full Text] [Related]
54. Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia.
Forthun RB; Hellesøy M; Sulen A; Kopperud RK; Sjøholt G; Bruserud Ø; McCormack E; Gjertsen BT
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1729-1749. PubMed ID: 31111215
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine.
Omsland M; Pise-Masison C; Fujikawa D; Galli V; Fenizia C; Parks RW; Gjertsen BT; Franchini G; Andresen V
Sci Rep; 2018 Jul; 8(1):11118. PubMed ID: 30042514
[TBL] [Abstract][Full Text] [Related]
56. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.
Hoshino H
Front Microbiol; 2012; 3():222. PubMed ID: 22737146
[TBL] [Abstract][Full Text] [Related]
57. Cell surface markers in HTLV-1 pathogenesis.
Kress AK; Grassmann R; Fleckenstein B
Viruses; 2011 Aug; 3(8):1439-59. PubMed ID: 21994790
[TBL] [Abstract][Full Text] [Related]
58. Current concepts regarding the HTLV-1 receptor complex.
Ghez D; Lepelletier Y; Jones KS; Pique C; Hermine O
Retrovirology; 2010 Nov; 7():99. PubMed ID: 21114861
[TBL] [Abstract][Full Text] [Related]
59. CD45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia.
Suzuki M; Matsuoka H; Yamashita K; Maeda K; Kawano K; Uno H; Tsubouchi H
Leuk Lymphoma; 1998 Feb; 28(5-6):583-90. PubMed ID: 9613989
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of CD45RO expression on peripheral blood mononuclear cells in HTLV-I-infected individuals.
Suzuki M; Uno H; Yamashita K; Toyama T; Kubuki Y; Maeda K; Matsuoka H; Ohtaki S; Tsubouchi H
Br J Haematol; 1996 Feb; 92(2):401-9. PubMed ID: 8603007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
